10-propargyl-10-deazaaminopterin and Lymphoma, B-Cell

10-propargyl-10-deazaaminopterin has been researched along with Lymphoma, B-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dumetrescu, O; Fleischer, M; Hamlin, PA; Horwitz, S; Macgregor-Cortelli, B; Moskowitz, CH; Mould, DR; Neylon, E; Noy, A; O'Connor, OA; Portlock, C; Sarasohn, D; Sirotnak, F; Straus, DJ; Zelenetz, AD	1

Trials

1 trial(s) available for 10-propargyl-10-deazaaminopterin and Lymphoma, B-Cell

Article	Year
Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier-type 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T-cell lymphoma. British journal of haematology, 2007, Volume: 139, Issue:3 Topics: Adult; Aged; Aminopterin; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Folic Acid Antagonists; Humans; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Membrane Transport Proteins; Middle Aged; Positron-Emission Tomography; Treatment Failure; Treatment Outcome	2007

Article

Year

Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier-type 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T-cell lymphoma.

British journal of haematology, 2007, Volume: 139, Issue:3

Topics: Adult; Aged; Aminopterin; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Folic Acid Antagonists; Humans; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Membrane Transport Proteins; Middle Aged; Positron-Emission Tomography; Treatment Failure; Treatment Outcome

2007